Tony Weisman
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
MNTN Announces Q3 2026 Results Date and Tealium Data Integration. MNTN will report its third‑quarter 2026 earnings on November 4, giving investors a clear timeline for upcoming financial data. In other news, the company has added Tealium’s first‑party data to its MNTN Matched™ platform, aiming to improve AI‑driven TV advertising targeting. These moves highlight MNTN’s focus on data‑enhanced advertising solutions and its scheduled earnings disclosure.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Crypto-linked stocks rebound; AI focus rises – impact on tech stocks. Crypto‑linked shares have climbed after a recent dip, showing a broader market recovery that can lift sentiment for tech names like KVYO. A Yahoo piece highlighted AI stocks for 2026, underscoring growing interest in tech innovation, though KVYO is not an AI firm. These developments may influence overall market dynamics for KVYO.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
CDLX: No company news in last 7 days. The only article in the last week reports that Similarweb’s stock fell after naming a new CEO. This development does not involve Cardlytics, so there is no direct impact on CDLX. The stock remains near its 52‑week low and is trading below its 14‑day RSI of 24.0, indicating a potential oversold condition.
Transaction History
| IBTA | ▲ Buy | Grant | 10,339 | $0 | 9/22/2026 | View on chart |
| MNTN | ▲ Buy | Grant | 46,893 | $0 | 6/11/2026 | View on chart |
| KVYO | ▲ Buy | Grant | 14,822 | $0 | 6/9/2026 | View on chart |
| KVYO | ▲ Buy | Grant | 5,820 | $0 | 6/10/2025 | View on chart |
| KVYO | ▼ Sell | Other | 75,000 | — | 12/12/2024 | View on chart |
| KVYO | ▼ Sell | Other | 20,833 | — | 12/12/2024 | View on chart |
| KVYO | ▲ Buy | Grant | 8,532 | $0 | 6/11/2024 | View on chart |
| KVYO | ▼ Sell | Other | 33,333 | — | 2/29/2024 | View on chart |
| KVYO | ▼ Sell | Open Market | 33,333 | $866K | 2/29/2024 | View on chart |
| CDLX | ▲ Buy | Option Exercise | 6,465 | — | 5/24/2023 | View on chart |
| CDLX | ▲ Buy | Option Exercise | 1,701 | $0 | 5/21/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Ibotta (IBTA) faces valuation questions amid rising sales expectations
Recent reports suggest Ibotta stock may be overvalued as sales expectations climb. This comes as the company draws attention for its position in the holiday shopping market, where toy prices have risen. The stock is currently trading near its 52-week high, with analysts setting a wide range for its future value.
Ibotta (IBTA) faces valuation questions amid rising sales expectations. Recent reports suggest Ibotta stock may be overvalued as sales expectations climb. This comes as the company draws attention for its position in the holiday shopping market, where toy prices have risen. The stock is currently trading near its 52-week high, with analysts setting a wide range for its future value.